Unimed's Marinol

Shipments of the antinausea agent Marinol (dronabinol) to "selected regional markets" began the week of July 14. The cannabinoid anti-emetic for cancer chemotherapy patients was approved in June 1985. However, the Drug Enforcement Agency did not complete rescheduling of the drug from Schedule I to Schedule II until April ("The Pink Sheet" April 7, T&G-2). Under a previously announced marketing agreement, Roxane will be responsible for final packaging, marketing and distribution of the drug.